Prelude Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$291K Buy
+12,167
New +$297K 0.02% 721
2022
Q4
Sell
-17,021
Closed -$211K 1401
2022
Q3
$211K Buy
+17,021
New +$298K 0.01% 1057
2021
Q2
Sell
-7,210
Closed -$212K 1710
2021
Q1
$212K Buy
+7,210
New +$222K 0.01% 1305
2020
Q4
Sell
-3,420
Closed -$96K 1459
2020
Q3
$96K Sell
3,420
-33,142
-91% -$840K ﹤0.01% 922
2020
Q2
$784K Buy
36,562
+36,207
+10,199% +$800K 0.04% 371
2020
Q1
$8K Buy
+355
New +$9.72K ﹤0.01% 1160
2018
Q4
Sell
-667
Closed -$23K 1869
2018
Q3
$23K Buy
+667
New +$23.5K ﹤0.01% 1283

Other funds holding ELAN

Prelude Capital Management's ELAN Position: Q1 2026 in Review

Prelude Capital Management opened a new position in Elanco Animal Health (ELAN) in Q1 2026: 12,167 shares worth $291K. The stake represents 0.02% of the portfolio and ranks #721 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in ELAN as recently as Q3 2022.

Prelude Capital Management first reported a position in ELAN in Q3 2018 and has held it in 7 quarters since. The position peaked at $784K in Q2 2020. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Prelude Capital Management held 12,167 shares of Elanco Animal Health worth $291K as of Q1 2026.
  • Elanco Animal Health was a new Prelude Capital Management position in Q1 2026.
  • Elanco Animal Health made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #721 holding.
  • Prelude Capital Management first reported a position in Elanco Animal Health in Q3 2018 and has held it in 7 quarters since.
  • Prelude Capital Management's Elanco Animal Health position peaked at $784K in Q2 2020.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.